Description
Palbociclib is a selective CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib is a drug for the treatment of ER-positive and HER2-negative breast cancer.
MolecularFormula
C24H29N7O2
Storage
Store at room temperature
BoilingPoint
711.5±70.0 ℃ at 760 mmHg
VapourPressure
0.0±2.3 mmHg at 25℃
Specification
an endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer.